The Parkinson’s Disease and Movement Disorders Program offers consultation, expertise and comprehensive care to individuals with neurological movement disorders. Ongoing, long-term care delivered by an interdisciplinary team of specialists provides patients with individualized care and access to the newest developments in treatment. Our team includes Neurologists who are Movement Disorder Specialists, nurses and rehabilitation specialists. In addition to standard care, patients may choose to participate in the latest clinical trials investigating new medications and therapies for treating Parkinson's disease. The Center offers the most current and innovative medical and surgical treatments for individuals with the following conditions including:
- Parkinson's disease
- Multiple system atrophy (MSA)
- Progressive supranuclear palsy (PSP)
- Huntington's disease
To learn more about our program in greater detail, please visit our Boston University Medical Campus Parkinson's Disease and Movement Disorders website.
To learn about pediatric movement disorders, please visit the Boston Medical Center Pediatric Movement Disorders page.
For information on patient appointments and treatment throughout the developing COVID-19 situation, please click here to see a note from our physicians.
We have two locations for outpatient consultation
Boston University Neurology Associates
Boston Medical Center
Shapiro Ambulatory Care Center
725 Albany St., 7th Floor
Boston, MA 02118
Boston University Neurology Associates
541 Main Street, Suite 317
Weymouth, MA 02190
Deep Brain Stimulation Program
The Deep Brain Stimulation (DBS) Program is a collaborative medical and surgical program for the treatment of Parkinson's disease, essential tremor, and dystonia. This interdisciplinary program includes neurosurgery, neurology, neuropsychiatry, behavioral medicine, anesthesiology, and nursing, providing state-of-the-art care for patients.
A multi-step screening process is used to select patients carefully for this procedure. Some patients who may be candidates for surgery include: 1) patients who do not have good movement control despite optimized medical therapy and 2) patients who have dyskinesia or other side effects that limit the use of Parkinson's medications.
In the selection process, patients are referred by their neurologist for a screening neurological consultation by the neurological DBS team members. Patients are evaluated with a brain MRI, neuropsychological testing, and movement testing with videotaping. Test results are reviewed by a panel of movement disorder specialists before referring the patient to the neurosurgeon for further evaluation. The patient is then seen and evaluated by the DBS neurosurgical director.
After DBS, patients receive follow-up neurological care and adjustments of medications and DBS neurostimulators. To learn more about the DBS Program at BMC, click here.
Clinical Research Program
The Parkinson Disease and Movement Disorders Center at Boston University Medical Campus has a long established clinical research program. Research is ongoing and includes observational and interventional research in pharmacology and rehabilitation.
Clinical research staff includes neurologists with specialty training in movement disorders, nurse specialists, and research assistants. Staff are members of the Parkinson Study Group and Huntington’s Study Group. The Center is designated an American Parkinson Disease Association Center for Advanced Research.
There are several ongoing research opportunities. For information, please contact Ray James, RN at (617) 638-7745. Listed below are trials currently recruiting subjects. Institutional Review Board approval has been obtained to publicize these trials.
- Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s Disease
- Study on Medication for Early Parkinson's (SPARK)
- Evaluation of a New Medication for Early Parkinson's (Pharma2B)
- Early Longitudinal Imaging in a Parkinson's Progression Markers Initiative (PPMI)
- Parkinson’s Progression Markers Initiative Study- Genetic Cohort (PPMI2)
- Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease (FIRE-UP PD)
- Biomarker Study (SEARCH PD)
- Walking Health is Paramount in Parkinson Disease (WHIP-PD)
- Biomarker Study (MICRO PD)- Ongoing Enrollment Complete
- Parkinson’s Progression Markers Initiative Study (PPMI) – Ongoing Enrollment Complete
- Social Self-Management in Parkinson’s Disease – Ongoing Enrollment Complete
APDA Center for Advanced Research
Boston University School of Medicine is home to an Advanced Center for Parkinson's Research supported by the American Parkinson Disease Association. The Center is directed by Marie Hélène Saint-Hilaire, MD, FRCPC, with a comprehensive team of experts.
APDA Centers for Advanced Research must meet the highest academic standards and be distinguished leaders in the field of PD research. There are eight such centers across the country
The funding of this Center supports a large research program, which includes: Biomarker studies, studies of non-motor symptoms, studies of self-management strategies, an active clinical trials program, 3500 patient visits per year, a Deep Brain Stimulation program, and a fellowship program in Movement Disorders.
The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to assist the more than 1 million Americans with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $170 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against Parkinson’s disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as our national Research Program and Centers for Advanced Research, please visit us at www.apdaparkinson.org
Parkinson's disease affects more than 1 million people in the United States annually, with at least 60,000 new cases diagnosed each year. The chronic and progressive neurological condition is the second most common neurodegenerative aging disorder, after Alzheimer's disease.
For more information contact:
Medical Director: Marie Hélène Saint-Hilaire, MD, FRCPC
E-mail: [email protected]
Patient Education and Support
American Parkinson’s Disease Association Information & Referral Center at Boston Medical Center
The Information & Referral Center was established at BUMC in 1980.
The Center serves as a resource for those with Parkinson's disease and their loved ones, as well as healthcare providers. Patients, caregivers, healthcare providers, and the greater community can receive support regardless of their affiliation with the hospital. Services include:
- A telephone helpline, (617) 638-8466 or (800) 651-8466
- A comprehensive resource referral network
- Support group assistance
- Counseling and guidance
- Training and support for healthcare professionals
- Implementation of regional conferences
- Participation in community awareness and public relations activities
- Maintaining an informational website
For information or to make an appointment, call the APDA Information & Referral Center at (617) 638-8466 or (800) 651-8466.
725 Albany Street
Boston, MA 02118
7th Foor, Suite 7B
Monday-Friday - 8:30 AM - 5:00 PM